Hb Leslie, an unstable hemoglobin due to deletion of glutaminyl residue beta 131 (H9) occurring in association with beta0-thalassemia, HbC, and HbS.
A new unstable hemoglobin, Hb Leslie, has been observed in three generations of a Georgia family. The propositus, a 42-yr-old black veteran with hemolytic anemia and splenomegaly, has a hemoglobin variant with an electrophoretic mobility similar to that of hemoglobin F. The variant comprises about 85% of the total hemoglobin and was isolated by chromatography. Chemical analysis has identified the abnormality as a deletion of the glutaminyl residue in position 131 (H9) of the beta-chain. Deletion of this critical residue which participates in the alpha1beta1 contact causes decreased stability of the hemoglobin without significant changes in functional properties or morphologic abnormalities in the erythrocyte. Family studies revealed hemoglobin Leslie occurring in combination with beta0-thalassemia, HbS, and HbC. All persons with the various Hb Leslie combinations, including the propositus, have no clinical manifestations other than anemia. In some the anemia is fully compensated. There is no history of drug-associated hemolysis.
D000293:Adolescent; D000328:Adult; D000595:Amino Acid Sequence; D000740:Anemia / Q000150:complications; D002648:Child; D002675:Child, Preschool; D002848:Chromatography, DEAE-Cellulose; D004592:Electrophoresis, Starch Gel; D005260:Female; D005973:Glutamine / Q000172:deficiency*; D006444:Hemoglobin C; D006451:Hemoglobin, Sickle; D006453:Hemoglobinopathies / Q000235:genetics; D006455:Hemoglobins, Abnormal; D006801:Humans; D008297:Male; D008875:Middle Aged; D010375:Pedigree; D013789:Thalassemia / Q000150:complications*
D006451:Hemoglobin, Sickle; D006455:Hemoglobins, Abnormal; D005973:Glutamine; D006444:Hemoglobin C